Vivos Therapeutics, Inc. VVOS NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score

56/100

3/7 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour Vivos Therapeutics, Inc. (VVOS), dont 41 achats et 6 ventes. Le total des achats d'initiés s'élève à $5.18M et le total des ventes d'initiés à $1.05M.

Les initiés notables ayant une activité récente comprennent Skaff Michael C, Johnson Gregg C, Amman Bradford K.. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — VVOS

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2026-03-31	Skaff Michael C	10 Percent Owner	Achat Informatif	429,957	$0.00	$43.00	429,957
2026-02-04	Johnson Gregg C	Director	Inconnu	-	-	-	3,997
2025-06-09	Skaff Michael C	10 Percent Owner	Inconnu	725,258	$0.00	$72.53	-
2024-11-26	Amman Bradford K.	Chief Financial Officer	Attribution de RSU	149,533	$2.64	$394.77K	180,533
2024-11-26	Huntsman Ronald Kirk	Chief Executive Officer	Attribution de RSU	315,421	$2.64	$832.71K	364,755
2024-06-20	Sokolow Leonard J	Director	Attribution de RSU	4,000	$2.38	$9.52K	7,467
2024-06-20	Krammer Anja B	Director	Attribution de RSU	4,000	$2.38	$9.52K	7,067
2024-06-20	Amman Bradford K.	Chief Financial Officer	Attribution de RSU	15,000	$2.38	$35.7K	31,667
2024-06-20	Thompson Matthew	Director	Attribution de RSU	4,000	$2.38	$9.52K	7,067
2024-06-20	Huntsman Ronald Kirk	Chief Executive Officer	Attribution de RSU	20,000	$2.38	$47.6K	49,334
2024-06-20	Lindsay Mark F.	Director	Attribution de RSU	4,000	$2.38	$9.52K	7,067
2024-06-20	Green Ralph Elias	Director	Attribution de RSU	4,000	$2.38	$9.52K	7,067
2024-06-10	Skaff Michael C	10 Percent Owner	Inconnu	3,220,266	$2.20	$7.1M	-
2023-06-20	Huntsman Ronald Kirk	Chief Executive Officer	Achat Informatif	14,000	$0.53	$7.42K	86,521
2023-06-16	Huntsman Ronald Kirk	Chief Executive Officer	Achat Informatif	10,000	$0.54	$5.4K	67,521
2023-06-15	Huntsman Ronald Kirk	Chief Executive Officer	Achat Informatif	21	$0.50	$10.50	57,521
2023-06-14	Huntsman Ronald Kirk	Chief Executive Officer	Achat Informatif	10,000	$0.49	$4.9K	57,500
2022-12-23	Sokolow Leonard J	Director	Attribution de RSU	30,000	$0.48	$14.4K	76,667
2022-12-23	Krammer Anja B	Director	Attribution de RSU	30,000	$0.48	$14.4K	76,667
2022-12-23	Amman Bradford K.	Chief Financial Officer	Attribution de RSU	200,000	$0.48	$96K	500,001
2022-12-23	Thompson Matthew	Director	Attribution de RSU	30,000	$0.48	$14.4K	76,667
2022-12-23	Huntsman Ronald Kirk	Chief Executive Officer	Achat Informatif	20,000	$0.50	$10K	47,500
2022-12-23	Lindsay Mark F.	Director	Attribution de RSU	30,000	$0.48	$14.4K	76,667
2022-12-23	Green Ralph Elias	Director	Attribution de RSU	30,000	$0.48	$14.4K	76,667
2022-05-31	Huntsman Ronald Kirk	Chief Executive Officer	Achat Informatif	8,000	$2.03	$16.24K	23,500
2022-02-25	Amman Bradford K.	Chief Financial Officer	Attribution de RSU	50,000	$3.27	$163.5K	50,000
2022-02-25	Huntsman Ronald Kirk	Chief Executive Officer	Attribution de RSU	125,000	$3.27	$408.75K	125,000
2021-09-21	Huntsman Ronald Kirk	Chief Executive Officer	Achat Informatif	5,000	$4.31	$21.55K	15,500
2021-08-31	Amman Bradford K.	Chief Financial Officer	Attribution de RSU	50,000	$5.26	$263K	50,000
2021-08-17	Huntsman Ronald Kirk	Chief Executive Officer	Achat Informatif	5,000	$3.00	$15K	10,500
2021-08-05	Sokolow Leonard J	Director	Attribution de RSU	30,000	$2.72	$81.6K	46,667
2021-08-05	Krammer Anja B	Director	Attribution de RSU	30,000	$2.72	$81.6K	46,667
2021-08-05	Thompson Matthew	Director	Attribution de RSU	30,000	$2.72	$81.6K	46,667
2021-08-05	Singh Gurdev Dave	10 Percent Owner, Officer: Chief Medical Officer	Attribution de RSU	30,000	$2.72	$81.6K	46,667
2021-08-05	Lindsay Mark F.	Director	Attribution de RSU	30,000	$2.72	$81.6K	46,667
2021-08-05	Green Ralph Elias	Director	Attribution de RSU	30,000	$2.72	$81.6K	46,667
2021-06-16	Huntsman Ronald Kirk	Chief Executive Officer	Attribution de RSU	125,000	$5.64	$705K	125,000
2021-05-25	Amman Bradford K.	Chief Financial Officer	Achat Informatif	1,000	$5.29	$5.29K	2,000
2021-05-25	Huntsman Ronald Kirk	Chief Executive Officer	Achat Informatif	4,000	$5.38	$21.52K	5,500
2021-03-12	Amman Bradford K.	Chief Financial Officer	Attribution de RSU	100,000	$7.50	$750K	100,000
2021-03-12	Amman Bradford K.	Chief Financial Officer	Attribution de RSU	100,000	$7.50	$750K	200,001
2020-12-24	Amman Bradford K.	Chief Financial Officer	Achat Informatif	1,000	$7.38	$7.38K	1,000
2020-12-23	Huntsman Ronald Kirk	10 Percent Owner, Officer: Chief Executive Officer	Achat Informatif	1,000	$7.27	$7.27K	1,500
2020-12-11	Huntsman Ronald Kirk	10 Percent Owner, Officer: Chief Executive Officer	Achat Informatif	500	$8.50	$4.25K	500
2020-12-10	Sokolow Leonard J	Director	Cession	16,667	$7.50	$125K	-
2020-12-10	Krammer Anja B	Director	Cession	16,667	$7.50	$125K	-
2020-12-10	Amman Bradford K.	Chief Financial Officer	Cession	16,667	$7.50	$125K	-
2020-12-10	Thompson Matthew	Director	Cession	16,667	$7.50	$125K	-
2020-12-10	Huntsman Ronald Kirk	10 Percent Owner, Officer: Chairman & CEO	Cession	333,334	$1.65	$550K	-
2020-12-10	Singh Gurdev Dave	10 Percent Owner, Officer: Chief Medical Officer	Cession	-	-	-	700,000

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration